XML 182 R139.htm IDEA: XBRL DOCUMENT v3.25.4
Other Consolidated Financial Statement Detail - Other Income (Expense), Net (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Apr. 30, 2022
Collaborative arrangements and non-collaborative arrangement transactions        
Interest income $ (125.0) $ (67.6) $ (276.5)  
Interest expense 267.5 250.3 246.9  
(Gains) losses on investments, net 19.7 100.4 291.2  
Litigation related expense 139.5 26.3 3.9  
Foreign exchange (gains) losses, net 28.6 30.9 50.4  
Other, net (24.7) 3.3 (0.4)  
Other (income) expense, net $ 305.6 $ 343.6 $ 315.5  
Samsung Bioepis        
Collaborative arrangements and non-collaborative arrangement transactions        
Ownership percentage       49.90%